Literature DB >> 23565351

NEXT STEP IN DRUG DELIVERY: GETTING TO INDIVIDUAL ORGANELLES.

Vladimir Torchilin1.   

Abstract

Entities:  

Year:  2012        PMID： 23565351      PMCID： PMC3615566          DOI： 10.1007/s13346-012-0102-2

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN： 2190-393X            Impact factor:   4.617


× No keyword cloud information.
  13 in total

Review 1.  Synthetic cell surface receptors for delivery of therapeutics and probes.

Authors:  David Hymel; Blake R Peterson
Journal:  Adv Drug Deliv Rev       Date:  2012-02-25       Impact factor: 15.470

2.  Raman microscopy for noninvasive imaging of pharmaceutical nanocarriers: intracellular distribution of cationic liposomes of different composition.

Authors:  T Chernenko; R R Sawant; M Miljkovic; L Quintero; M Diem; V Torchilin
Journal:  Mol Pharm       Date:  2012-03-15       Impact factor: 4.939

Review 3.  Cell-penetrating peptides: breaking through to the other side.

Authors:  Erez Koren; Vladimir P Torchilin
Journal:  Trends Mol Med       Date:  2012-06-07       Impact factor: 11.951

Review 4.  Recent approaches to intracellular delivery of drugs and DNA and organelle targeting.

Authors:  Vladimir P Torchilin
Journal:  Annu Rev Biomed Eng       Date:  2006       Impact factor: 9.590

Review 5.  Enzyme replacement therapy for lysosomal storage diseases.

Authors:  Robin H Lachmann
Journal:  Curr Opin Pediatr       Date:  2011-12       Impact factor: 2.856

6.  Surface modification of liposomes with rhodamine-123-conjugated polymer results in enhanced mitochondrial targeting.

Authors:  Swati Biswas; Namita S Dodwadkar; Rupa R Sawant; Alexander Koshkaryev; Vladimir P Torchilin
Journal:  J Drug Target       Date:  2011-02-25       Impact factor: 5.121

Review 7.  Targeting mitochondria in fighting cancer.

Authors:  Vladimir Gogvadze
Journal:  Curr Pharm Des       Date:  2011-12-01       Impact factor: 3.116

8.  Stearylated INF7 peptide enhances endosomal escape and gene expression of PEGylated nanoparticles both in vitro and in vivo.

Authors:  Ayman El-Sayed; Tomoya Masuda; Hidetaka Akita; Hideyoshi Harashima
Journal:  J Pharm Sci       Date:  2011-11-15       Impact factor: 3.534

9.  Surface conjugation of triphenylphosphonium to target poly(amidoamine) dendrimers to mitochondria.

Authors:  Swati Biswas; Namita S Dodwadkar; Aleksandr Piroyan; Vladimir P Torchilin
Journal:  Biomaterials       Date:  2012-04-01       Impact factor: 12.479

Review 10.  pH-sensitive liposomes--principle and application in cancer therapy.

Authors:  H Karanth; R S R Murthy
Journal:  J Pharm Pharmacol       Date:  2007-04       Impact factor: 3.765
View more
  2 in total

1.  Therapeutic efficacy of combining pegylated liposomal doxorubicin and radiofrequency (RF) ablation: comparison between slow-drug-releasing, non-thermosensitive and fast-drug-releasing, thermosensitive nano-liposomes.

Authors:  Alexander V Andriyanov; Erez Koren; Yechezkel Barenholz; S Nahum Goldberg
Journal:  PLoS One       Date:  2014-05-01       Impact factor: 3.240

2.  High Content Analysis Across Signaling Modulation Treatments for Subcellular Target Identification Reveals Heterogeneity in Cellular Response.

Authors:  Sayan Biswas
Journal:  Front Cell Dev Biol       Date:  2021-01-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.